Trials / Completed
CompletedNCT01474655
Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal
Assessment of Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the changes in visual acuity, metamorphopsia, and thickness of retinal layers after epiretinal membrane removal and to investigate factors associated with visual function.
Detailed description
Eyes with idiopathic Epiretinal Membrane Removal (ERM) scheduled to underwent ERM removal were included. Changes in visual acuity, metamorphopsia score (M-score) using M-chart, and parafoveal thickness of each retinal layer were evaluated preoperatively and at 2-month and 6-month postoperative follow-up visits. Factors associated with visual acuity and M-score were investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pars plana vitrectomy and removal of epiretinal membrane | A three-port standard pars plana vitrectomy was performed by a single surgeon using a 23-gauge vitrectomy system, either Associate®(Dutch Ophthalmic Research Center. Inc., Zuidland, The Netherlands) or Accurus®(Alcon Laboratories Inc., Fort Worth, USA), with one step scleral tunnel incision. Visualization of the fundus was achieved using a wide-angle viewing system. After core vitrectomy, induction of a posterior vitreous detachment was conducted using a 23-gauge angulated dissecting needle in cases without presence of a posterior vitreous detachment. The epiretinal membrane and internal limiting membrane was removed in all eyes. In most cases, internal limiting membrane was removed without the assistance of staining dye. Indocyanine green dye was used to facilitate the removal of internal limiting membrane in some of the cases. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2011-11-18
- Last updated
- 2011-11-18
Source: ClinicalTrials.gov record NCT01474655. Inclusion in this directory is not an endorsement.